Lower riskMedical device recall · FDA · Published June 3, 2026
Remel GC Agar Base Recall: Reduced Neisseria gonorrhoeae recovery risk
Remel recalls two types of GC Agar Base (150mm and 100mm) due to reduced recovery of Neisseria gonorrhoeae strains. Affected units have specific lot numbers and model codes.
“Remel GC Agar Base Recall: Reduced Neisseria gonorrhoeae recovery risk.” GovInfoNow, updated August 10, 2026. https://govinfonow.com/recall/49045-remel-gc-agar-base-recall-reduced-neisseria-gonorrhoeae-recovery-risk. Based on FDA recall #Z-2623-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2623-2026%22&limit=1).
The FDA announced on June 3, 2026, that Remel, Inc. is recalling GC Agar Base products due to the hazard of reduced or no recovery of some strains of Neisseria gonorrhoeae. The agency issued recall number Z-2623-2026 for the voluntary Class II recall.
Distribution: US Nationwide, Canada, Singapore, and the United Kingdom
The hazard
According to the FDA, the recalled GC Agar Base products pose a hazard of reduced or no recovery of some strains of Neisseria gonorrhoeae.
Context
GovInfoNow's records show Remel, Inc. has 22 other recalls on record since November 2, 2017. Other recent recalls of similar products include the Remel Yeastone Broth Recall (March 24, 2026), the Remel Campy CVA Medium 100/PK recall (February 5, 2026), and the Remel Lab Culture Media Recall (November 12, 2025). Other recent recalls of similar products include the Remel Neisseria meningitidis Gp C 2ml/VL recall (July 17, 2026), the GET TESTED Gonorrhea Test Recall (November 3, 2025), and the Remel Oxoid Agglutinating Sera Recall (March 25, 2026).
How to tell if you have this one
Check for model codes R04030 (150mm) or R01460 (100mm) with specific lot numbers listed in the recall notice. The products were sold with unique identifiers (UDI-DI) starting with 84883800.
Brand
Remel
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Product Details
Identify the model code (R04030 or R01460) and lot numbers listed in the recall notice.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
Nationwide
Not listed
FDA distribution: “Worldwide distribution - US Nationwide and the countries of Canada, Singapore, and the United Kingdom.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA published this recall 35 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-2623-2026 (June 3, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2623-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.